title: Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
authors.affiliation: Department of Medicine, Vanderbilt University School of Medicine; Allergy and Asthma Specialists, PLLC, Nashville, Tenn. Electronic address: wolfatthelair@comcast.net.
authors.forename: Bruce L
authors.initials: BL
authors.lastname: Wolf
authors.affiliation: Allergy and Asthma Specialists, PLLC, Nashville, Tenn.
authors.forename: Ashley
authors.initials: A
authors.lastname: Johnson
mesh_terms: D000369:Aged, 80 and over; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000097:blood*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000276:immunology*; D015415:Biomarkers / Q000097:blood; D015536:Down-Regulation; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D008297:Male; D000069444:Omalizumab; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000907:Antibodies, Bacterial; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D000069444:Omalizumab; D007073:Immunoglobulin E